Ryanodine receptor dispersion disrupts Ca2+ release in failing cardiac myocytes

Abstract

Reduced cardiac contractility during heart failure (HF) is linked to impaired Ca2+ release from Ryanodine Receptors (RyRs). We investigated whether this deficit can be traced to nanoscale RyR reorganization. Using super-resolution imaging, we observed dispersion of RyR clusters in cardiomyocytes from post-infarction HF rats, resulting in more numerous, smaller clusters. Functional groupings of RyR clusters which produce Ca2+ sparks (Ca2+ release units, CRUs) also became less solid. An increased fraction of small CRUs in HF was linked to augmented 'silent' Ca2+ leak, not visible as sparks. Larger multi-cluster CRUs common in HF also exhibited low fidelity spark generation. When successfully triggered, sparks in failing cells displayed slow kinetics as Ca2+ spread across dispersed CRUs. During the action potential, these slow sparks protracted and desynchronized the overall Ca2+ transient. Thus, nanoscale RyR reorganization during HF augments Ca2+ leak and slows Ca2+ release kinetics, leading to weakened contraction in this disease.

Data availability

Source data files have been provided for Figures 2 , 4 and 6.All raw data acquired and analyzed in this study are publicly available in the following repository: https://github.com/TerjePrivate/Ryanodine_Receptor_Dispersion_during_Heart_Failure

Article and author information

Author details

  1. Terje R Kolstad

    Insitute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0589-5689
  2. Jonas van den Brink

    Simula Reseach Laboratory, Fornebu, Norway
    Competing interests
    The authors declare that no competing interests exist.
  3. Niall MacQuaide

    Institute of Cardiovascular Sciences, University of Glasgow, Glasgow, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Per Kristian Lunde

    Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.
  5. Michael Frisk

    Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.
  6. Jan Magnus Aronsen

    Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.
  7. Einar Sjaastad Norden

    Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.
  8. Alessandro Cataliotti

    Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.
  9. Ivar Sjaastad

    Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.
  10. Ole Mathias Sejersted

    Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8817-3296
  11. Andrew G Edwards

    Simula Research Laboratory, Fornebu, Norway
    Competing interests
    The authors declare that no competing interests exist.
  12. Glenn Terje Lines

    Simula Research Laboratory, Fornebu, Norway
    Competing interests
    The authors declare that no competing interests exist.
  13. William Edward Louch

    Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway
    For correspondence
    w.e.louch@medisin.uio.no
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0511-6112

Funding

Horizon 2020 Framework Programme (Consolidator grant for WEL 647714)

  • Terje R Kolstad
  • William Edward Louch

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experiments were approved by the Norwegian National Animal Research Authority (project license no. FOTS 5982, 7786), and were performed in accordance with the National Institute of Health guidelines (NIH publication No. 85-23, revised 2011) and European Directive 2010/63/EU.

Copyright

© 2018, Kolstad et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Terje R Kolstad
  2. Jonas van den Brink
  3. Niall MacQuaide
  4. Per Kristian Lunde
  5. Michael Frisk
  6. Jan Magnus Aronsen
  7. Einar Sjaastad Norden
  8. Alessandro Cataliotti
  9. Ivar Sjaastad
  10. Ole Mathias Sejersted
  11. Andrew G Edwards
  12. Glenn Terje Lines
  13. William Edward Louch
(2018)
Ryanodine receptor dispersion disrupts Ca2+ release in failing cardiac myocytes
eLife 7:e39427.
https://doi.org/10.7554/eLife.39427

Share this article

https://doi.org/10.7554/eLife.39427

Further reading

    1. Cell Biology
    2. Developmental Biology
    Sarah Y Coomson, Salil A Lachke
    Insight

    A study in mice reveals key interactions between proteins involved in fibroblast growth factor signaling and how they contribute to distinct stages of eye lens development.

    1. Cell Biology
    2. Evolutionary Biology
    Paul Richard J Yulo, Nicolas Desprat ... Heather L Hendrickson
    Research Article

    Maintenance of rod-shape in bacterial cells depends on the actin-like protein MreB. Deletion of mreB from Pseudomonas fluorescens SBW25 results in viable spherical cells of variable volume and reduced fitness. Using a combination of time-resolved microscopy and biochemical assay of peptidoglycan synthesis, we show that reduced fitness is a consequence of perturbed cell size homeostasis that arises primarily from differential growth of daughter cells. A 1000-generation selection experiment resulted in rapid restoration of fitness with derived cells retaining spherical shape. Mutations in the peptidoglycan synthesis protein Pbp1A were identified as the main route for evolutionary rescue with genetic reconstructions demonstrating causality. Compensatory pbp1A mutations that targeted transpeptidase activity enhanced homogeneity of cell wall synthesis on lateral surfaces and restored cell size homeostasis. Mechanistic explanations require enhanced understanding of why deletion of mreB causes heterogeneity in cell wall synthesis. We conclude by presenting two testable hypotheses, one of which posits that heterogeneity stems from non-functional cell wall synthesis machinery, while the second posits that the machinery is functional, albeit stalled. Overall, our data provide support for the second hypothesis and draw attention to the importance of balance between transpeptidase and glycosyltransferase functions of peptidoglycan building enzymes for cell shape determination.